Pregnancy involves rapid physiological adaptation and complex interplay between mother and fetus. New analytic technologies provide large amounts of genomic, proteomic, and metabolomics data. The integration of these data through bioinformatics, statistical, and systems pharmacology techniques can improve our understanding of the mechanisms of normal maternal physiologic changes and fetal development. New insights into the mechanisms of pregnancy-related disorders, such as preterm birth (PTB), may lead to the development of new therapeutic interventions and novel biomarkers
The “omics” technologies represent a new model of approach in the study of human disease. It consist...
Preterm birth (PTB) is a large public health problem in the United States and worldwide. There is a ...
Background: Spontaneous preterm birth is a complex syndrome with multiple pathways interactions dete...
The prediction or early diagnosis of maternal complications is challenging mostly because the main c...
Preterm birth is the leading cause of neonatal mortality and perinatal morbidity. The etiology of pr...
The prediction or early diagnosis of maternal complications is challenging mostly because the main c...
Metabolomics in maternal-fetal medicine is still an "embryonic" science. However, there is already a...
This paper describes a metabonomics study of 2nd trimester biofluids (amniotic fluid, maternal urine...
The prediction or early diagnosis of maternal complications is challenging mostly because the main c...
Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic und...
Pregnancy is a complicated and insidious state with various aspects to consider, including the well-...
Pregnancy is a dynamic state of maternal immunologic adaptation during which women undergo intense a...
Gestational diabetes mellitus, intrauterine growth restriction, and preeclamptic toxemia are common ...
Background: Clinical metabolomics is a growing field of research aiming to use metabolomic techniqu...
Pregnant women, fetuses, and newborns are particularly vulnerable patient populations. During pregna...
The “omics” technologies represent a new model of approach in the study of human disease. It consist...
Preterm birth (PTB) is a large public health problem in the United States and worldwide. There is a ...
Background: Spontaneous preterm birth is a complex syndrome with multiple pathways interactions dete...
The prediction or early diagnosis of maternal complications is challenging mostly because the main c...
Preterm birth is the leading cause of neonatal mortality and perinatal morbidity. The etiology of pr...
The prediction or early diagnosis of maternal complications is challenging mostly because the main c...
Metabolomics in maternal-fetal medicine is still an "embryonic" science. However, there is already a...
This paper describes a metabonomics study of 2nd trimester biofluids (amniotic fluid, maternal urine...
The prediction or early diagnosis of maternal complications is challenging mostly because the main c...
Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic und...
Pregnancy is a complicated and insidious state with various aspects to consider, including the well-...
Pregnancy is a dynamic state of maternal immunologic adaptation during which women undergo intense a...
Gestational diabetes mellitus, intrauterine growth restriction, and preeclamptic toxemia are common ...
Background: Clinical metabolomics is a growing field of research aiming to use metabolomic techniqu...
Pregnant women, fetuses, and newborns are particularly vulnerable patient populations. During pregna...
The “omics” technologies represent a new model of approach in the study of human disease. It consist...
Preterm birth (PTB) is a large public health problem in the United States and worldwide. There is a ...
Background: Spontaneous preterm birth is a complex syndrome with multiple pathways interactions dete...